According to our findings, the administration of icv-STZ exacerbated the disease progression of AD via gliosis that resulted from an increases in the levels of fecal PPA and the inactive form of GSK3β in 3 × Tg-AD mice. The gene discussed is GSK3B; the disease is Alzheimer disease.